Simple nasal spray may prevent hearing loss in cancer survivors
NCT ID NCT07189572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a steroid nasal spray can prevent fluid buildup in the middle ear, a common side effect of radiation therapy for nasopharyngeal cancer. About 168 adults who are about to start radiation will use either the spray or a placebo for 12 months. The goal is to see if this simple, non-invasive treatment can reduce ear fullness and hearing loss, improving quality of life without the need for ear tubes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Can a tiny ear tube offer lasting relief for middle ear infections?
- Can precision protons spare the bowel in prostate cancer?
- Could adding extra chemo before standard therapy beat nasopharyngeal cancer?
- Can shorter radiation schedules spare breast skin?
- Can smarter surveillance sharpen pneumonia vaccines?